Search research articles
Contact Us
Filters
Showing results (321-330 of 596) with videos related to
Page
of 60
Sort By:
Breast Cancer Research and Treatment
|
January 27, 2009
A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines
Alan Mackay, Narinder Tamber, Kerry Fenwick, et al.
The Journal of Urology
|
September 1, 1989
Treatment of impotence by intrapenile injections. A comparison of papaverine versus papaverine and phentolamine: a double-blind, crossover trial
E J Keogh, G R Watters, C M Earle, et al.
Nature
|
July 14, 1972
Female homosexuality
A J Eisinger, R G Huntsman, J Lord, et al.
British Journal of Cancer
|
November 15, 2017
Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006-2014)
Benjamin Daniels, Belinda E Kiely, Nehmat Houssami, et al.
Scandinavian Journal of Immunology
|
January 11, 2007
Diabetes induces rapid suppression of adaptive immunity followed by homeostatic T-cell proliferation
B Luo, W F N Chan, S J Lord, et al.
Plos One
|
November 21, 2012
Secretory vesicles are preferentially targeted to areas of low molecular SNARE density
Lei Yang, Alison R Dun, Kirsty J Martin, et al.
Journal of Occupational and Environmental Medicine
|
January 15, 2019
Integrated Physical Medicine at Employer-Sponsored Health Clinics Improves Quality of Care at Reduced Cost
Daniel J Lord, John R Wright, Rebecca Fung, et al.
Science Advances
|
March 26, 2025
Proteogenomic discovery of <i>RB1</i>-defective phenocopy in cancer predicts disease outcome, response to treatment, and therapeutic targets
Jacopo Iacovacci, Rachel Brough, Fatemeh Ahmadi Moughari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 24, 2016
Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR-Mutated Non-Small Cell Lung Cancer
Pei Ni Ding, Sarah J Lord, Val Gebski, et al.
JCO Precision Oncology
|
January 8, 2024
Framework for the Use of External Controls to Evaluate Treatment Outcomes in Precision Oncology Trials
Derrick H W Siu, Frank P Y Lin, Doah Cho, et al.
Page
of 60
Search research articles
Search
Showing results (321-330 of 596) with videos related to
Sort By:
Page
of 60
Breast Cancer Research and Treatment
|
January 27, 2009
A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines
Alan Mackay, Narinder Tamber, Kerry Fenwick, et al.
The Journal of Urology
|
September 1, 1989
Treatment of impotence by intrapenile injections. A comparison of papaverine versus papaverine and phentolamine: a double-blind, crossover trial
E J Keogh, G R Watters, C M Earle, et al.
Nature
|
July 14, 1972
Female homosexuality
A J Eisinger, R G Huntsman, J Lord, et al.
British Journal of Cancer
|
November 15, 2017
Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006-2014)
Benjamin Daniels, Belinda E Kiely, Nehmat Houssami, et al.
Scandinavian Journal of Immunology
|
January 11, 2007
Diabetes induces rapid suppression of adaptive immunity followed by homeostatic T-cell proliferation
B Luo, W F N Chan, S J Lord, et al.
Plos One
|
November 21, 2012
Secretory vesicles are preferentially targeted to areas of low molecular SNARE density
Lei Yang, Alison R Dun, Kirsty J Martin, et al.
Journal of Occupational and Environmental Medicine
|
January 15, 2019
Integrated Physical Medicine at Employer-Sponsored Health Clinics Improves Quality of Care at Reduced Cost
Daniel J Lord, John R Wright, Rebecca Fung, et al.
Science Advances
|
March 26, 2025
Proteogenomic discovery of <i>RB1</i>-defective phenocopy in cancer predicts disease outcome, response to treatment, and therapeutic targets
Jacopo Iacovacci, Rachel Brough, Fatemeh Ahmadi Moughari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 24, 2016
Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR-Mutated Non-Small Cell Lung Cancer
Pei Ni Ding, Sarah J Lord, Val Gebski, et al.
JCO Precision Oncology
|
January 8, 2024
Framework for the Use of External Controls to Evaluate Treatment Outcomes in Precision Oncology Trials
Derrick H W Siu, Frank P Y Lin, Doah Cho, et al.
Page
of 60